Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

http://www.wikidata.org/entity/Q43086415

about

Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease Osteopontin and mucosal protection Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.Small therapeutic molecules for the treatment of inflammatory bowel disease Immunoregulation in the gut: success and failures in human disease.Inflammatory bowel disease: new insights into pathogenesis and treatment.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Transient inflammatory-like state and microbial dysbiosis are pivotal in establishment of mucosal homeostasis during colonisation of germ-free mice.Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage.Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.Fistulising Crohn's disease: MMPs gone awry.Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease Mechanisms of infliximab: the reverse side of a drug effect.Immunopathogenesis of IBD: current state of the art.Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis Immunopathogenesis of Crohn's disease.The anti-inflammatory effects of enteral nutrition.Synergy between immunosuppressive therapy and enteral nutrition in the management of childhood Crohn's disease.Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.Fibrogenesis in Crohn's disease.Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications.Selective gelatinase blockage ameliorates acute DSS colitis.The distinct roles of MMP-2 and MMP-9 in acute DSS colitis.The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 ameliorates acute DSS colitis.Proteases and the gut barrier.Matrix metalloproteinases: do they play a role in mucosal pathology of the oral cavity?Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1β-stimulated colon cancer cells.Matrix metalloproteinase-1 expression induced by IL-1beta requires acid sphingomyelinase.Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice.A place for TACE.Expression of matrix metalloproteinases and tissue inhibitor metalloproteinases increases in X-irradiated rat ileum despite the disappearance of CD8a T cells.Cellular and molecular mechanisms of intestinal fibrosis.Effect of the anti-tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease.

P2860

Q24669999-7AE821E7-B5F6-4AA7-9C51-E124CA385F76 Q28236080-0ACAF3B2-8027-4966-9AE7-AA481F2C8801 Q33507287-5CCB3ADE-BD45-479D-AD80-E8835BE16F0E Q33692376-40EC0BB7-2CED-4330-8147-B6BEC30C9949 Q34381832-7B956DDD-97D7-47EC-B14B-52E3DA5A9683 Q34382826-A1E20772-D2F4-4BC5-9D0A-F65ED63E3516 Q34600992-E2A06DEE-5BB5-4C90-927C-E9BA169EBB80 Q34601009-FE1409AC-8C36-4F7B-865C-F4704F455F91 Q35020743-0D8F5FE9-BCA4-4CA3-A2BB-17364DA0468A Q35022269-C3EFC12E-70E7-41D6-AB1B-F89B84980A1D Q35063393-B65ED60B-E203-4138-8BBB-9ED359148B1C Q35594688-9CB23936-47CC-4541-B32A-DED7FD6575E9 Q35596475-D30CA108-B0C4-4667-B9EC-0C74C44D433C Q35745017-3FCF020C-002B-43B9-A950-F4D7397BA22D Q35749265-7B6AF1A5-DE84-4FA3-A9D1-FB8DABF001F7 Q35787649-0B966CFA-DCCA-4D60-A214-3DEC7A6F618A Q35857951-5300679B-2D65-46FB-97D2-D13D1882E6D8 Q36166985-7B73FDCB-F94F-4ABE-BAD6-BDBA13C237D6 Q36175758-92CF0554-4D7E-45D3-A7E0-FD6279322DB6 Q36175765-3F308F52-1F46-4C1E-8021-C13D5BDA93D0 Q36175772-17240348-F763-401B-AAAD-450311BF3B50 Q36180595-F0F84D98-8FDA-44D2-A5B8-D563CBA7DC1C Q36677634-B090CF38-A2DD-46A5-B68E-8FF35245271E Q36700657-A24DAC45-FCA8-4757-93B8-0DCCC2D08AB5 Q37000242-50F1EBE3-5C9F-45B2-BC1A-AB9922A9B07F Q37531258-EE973E9C-7DC2-403F-B92C-8140F594E0E1 Q37568945-F2E20C3F-F8A8-4D4F-B3C7-C50EFEA09A08 Q37656421-A30BEF24-53C8-4E71-9642-6D3FC8A55383 Q37994635-6B724E55-726D-4B26-B51C-B293FB54B5AF Q38049159-3A30CA9C-389B-4F58-BB0C-0AA860C35B34 Q38681986-121E4BC6-202A-4CBC-93CF-B7A489A01F74 Q38881849-FE037679-BCB9-4F54-AE05-B73EC8492E64 Q39380237-C93DE62E-D751-49C8-AD4D-D3B9273590C4 Q39870204-446AC71E-2A11-43A4-8CE2-BF1B8B7D0885 Q39896496-BA11D2BA-DE49-4287-84E1-08A0A75495D4 Q40214318-877003E0-6B06-44BE-B3F5-1912A5BD17AD Q41894206-A44174E0-CD96-4648-97B8-B886B828864E Q42104313-C3485837-6332-433D-9401-C04BA0F12FAA Q42252132-7BC149FE-419D-44EF-B01B-E84625385F8B Q42506425-2491E88E-DED9-4BCC-A783-A0BA173931E1

P2860

Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

http://www.wikidata.org/entity/Q43086415

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh-hant

name

Imbalance of stromelysin-1 and ...... th inflammatory bowel disease.

@en

Imbalance of stromelysin-1 and ...... th inflammatory bowel disease.

@nl

type

label

Imbalance of stromelysin-1 and ...... th inflammatory bowel disease.

@en

Imbalance of stromelysin-1 and ...... th inflammatory bowel disease.

@nl

prefLabel

Imbalance of stromelysin-1 and ...... th inflammatory bowel disease.

@en

Imbalance of stromelysin-1 and ...... th inflammatory bowel disease.

@nl

P1433

Q43086415-2422A94C-EDE9-4ADC-A7CD-7DBB6F4C0E03

P1476

Q43086415-A002D67F-B942-4667-9C40-262B9A061747

P2093

Q43086415-2F1EE281-A949-4321-A56A-599F7C312E8D

Q43086415-4F8AC64D-4C17-446C-A886-34BB60F84226

Q43086415-8745A9BC-FB55-4B27-A54F-3D1C2B2C244A

Q43086415-ABD1A04C-1915-483D-AAD8-B32F67AE527A

Q43086415-B2D15569-E91F-4875-A932-811943E3AAAF

P2860

Q43086415-03A03746-C063-42E3-B89A-4D3BC48CECDE

Q43086415-0CC03DAC-580C-4F27-B9AC-8A6AB5B87CA7

Q43086415-0CC98830-2AB0-4131-A430-764B519F117B

Q43086415-149EB5A1-735E-4A5A-AF7A-5371B35D352A

Q43086415-163D5331-6D67-4866-B1DF-02709FAA06E9

Q43086415-1A3E43C9-4A81-430A-8B84-D241B53E2307

Q43086415-32EA5F4B-B00F-4F5A-8D9C-A036450586AF

Q43086415-3DD18B13-7CCC-4A55-ACCD-A2AA4CBCAA41

Q43086415-4702256D-0A05-45CC-A384-004ABDC21CC3

Q43086415-47C9A06B-17B7-4EE8-8F91-8383DAA55F73

P304

Q43086415-8B71776B-DF05-444F-A43E-BE7CB970D666

P31

Q43086415-FF511EB4-BD5E-4A16-AC32-937EEB9BA973

P356

Q43086415-736DC828-EDC4-40D5-8179-AB642B617F08

P407

Q43086415-58AFE788-DAA1-4183-8A4A-4178D5D7EC52

P433

Q43086415-B5ED4BCC-0CE8-4C5A-8959-794DC214064C

P478

Q43086415-7AFADC26-AC06-4E61-BEF7-2CFF0DA672DA

P50

Q43086415-7E24672C-44B3-42F3-8AB5-2F2A1BC5F4F4

P577

Q43086415-10FB0D92-71FC-4ED9-B1B6-CEBFFE2A4E61

P5875

Q43086415-6A4577A0-C4D8-4F4E-9966-C4524FE675AA

P698

Q43086415-B75FD222-F746-4420-B5D0-385651D48BC8

P932

Q43086415-27578539-6F2E-4DAD-9569-AA7379FE0D27

P356

P1433

P1476

Imbalance of stromelysin-1 and ...... ith inflammatory bowel disease

@en

P2093

G Monteleone

http://www.w3.org/2001/XMLSchema#string

J A Smith

http://www.w3.org/2001/XMLSchema#string

R B Heuschkel

http://www.w3.org/2001/XMLSchema#string

S L Pender

http://www.w3.org/2001/XMLSchema#string

T T MacDonald

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.

Activation of extracellular matrix metalloproteases by proteases and organomercurials.

Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.

Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.

Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation.

Development and validation of a pediatric Crohn's disease activity index.

Plasminogen activators and matrix metalloproteinases in angiogenesis.

A major role for matrix metalloproteinases in T cell injury in the gut.

P304

57-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.47.1.57

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

M Bajaj-Elliott

P577

2000-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12457969

http://www.w3.org/2001/XMLSchema#string

P698

10861265

http://www.w3.org/2001/XMLSchema#string

P932

1727949

http://www.w3.org/2001/XMLSchema#string